Tilray Brands (TSE:TLRY) Price Target Raised to C$13.60

Tilray Brands (TSE:TLRY) had its price objective lifted by Sanford C. Bernstein from C$13.00 to C$13.60 in a research report released on Friday,BayStreet.CA reports.

Tilray Brands Trading Down 9.7%

Shares of TLRY opened at C$15.31 on Friday. Tilray Brands has a 12-month low of C$4.90 and a 12-month high of C$32.30. The company has a quick ratio of 2.16, a current ratio of 2.54 and a debt-to-equity ratio of 10.76. The firm has a market capitalization of C$1.78 billion, a price-to-earnings ratio of -0.63 and a beta of 3.56. The stock’s 50-day moving average price is C$16.38 and its 200 day moving average price is C$13.92.

About Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.